Clin J Am Soc Nephrol 3: A5-, 2008
© 2008 American Society of Nephrology
Continuing Medical Education Information
 |
Continuing Medical Education Information
|
|---|
Date of Original Release: This C-JASN supplement is based on an official ASN continuing medical education (CME) luncheon symposium held November 16, 2006, in San Diego, CA.
CME Credit Eligible Through: December 31, 2008
CME Credit: 2.0 AMA PRA Category 1 CreditsTM
Target Audience: Physicians in internal medicine, nephrology, endocrinology, and others interested in the treatment of hypertension and kidney disease
Method of Participation: Read the supplement, which is supplemented by original articles in the reference lists, and complete the examination.
Scoring: Answer 
80% correct, and receive answers to the questions; full CME credit is provided on first submission.
|
Accreditation and Credit Designation
|
|---|
The American Society of Nephrology (ASN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASN designates this educational activity (entire supplement) for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Learning Objectives:
|
|---|
- To examine the epidemiology and pathophysiology of stroke and cardiovascular disease in the chronic kidney disease population
- To evaluate the efficacy of current therapies for the treatment of cardiovascular risk in patients with renal disease
- To apply new clinical insights for the identification and treatment of cardiovascular risk to improve outcomes for patients with chronic kidney disease
|
Faculty Disclosure Information
|
|---|
It is policy at ASN for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interests that provide products or services that may be relevant to the content of the CME activity. For this purpose, we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. A peer-review process is conducted for all content. In addition, all faculty are instructed to provide balanced, scientifically rigorous, and evidence-based presentations. The editorial board and editorial authors have reported the listed financial relationships with commercial interests related to the content of this CME activity.
Bakris, George—Grants or research support: National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases/National Heart, Lung, and Blood Institute), GlaxoSmithKline, Gilead, Forest, Sanofi; consultantships: Abbott, Boehringer Ingelheim, BMS/Sanofi-Aventis, Forest, Gilead, GlaxoSmithKline, Merck, Novartis, Walgreen’s Formulary Committee, Sankyo; editorial board: Kidney International, Diabetes Care, Hypertension, Journal of Clinical Hypertension, Translational Medicine, Journal of Clinical Pharmacology, Nephrology, Dialysis and Transplant; editor: American Journal of Nephrology; member: ASN Hypertension Executive Committee.
Linas, Stuart—Consultantships: Merck, AstraZeneca, Gilead; honoraria: Merck, AstraZeneca, Pfizer, Novartis; chair: ASN Hypertension Advisory Group.
McCaffrey, Eileen (Medical Writer)—None.
Townsend, Raymond—Grants or research support: Novartis (ACCOMPLISH trial), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; consultantships: GlaxoSmithKline, Atcor Medical, Abbott Laboratories; honoraria: Merck, Bristol-Myers Squibb, Pfizer; associate editor: Nephrology Self-Assessment Program (NephSAP); financial relationship: UpToDate, PIER (ACP/ASIM).
|
Commercial Support
|
|---|
Support for this activity is provided by an educational grant from Boehringer Ingelheim.
Top
Continuing Medical Education...
Accreditation and Credit...
